BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 19584271)

  • 1. The emerging role of EpCAM in cancer and stem cell signaling.
    Munz M; Baeuerle PA; Gires O
    Cancer Res; 2009 Jul; 69(14):5627-9. PubMed ID: 19584271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of hepatic stem cell marker EpCAM by Wnt-beta-catenin signaling in hepatocellular carcinoma.
    Yamashita T; Budhu A; Forgues M; Wang XW
    Cancer Res; 2007 Nov; 67(22):10831-9. PubMed ID: 18006828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epithelial cell adhesion molecule expression (CD326) in cancer: a short review.
    Patriarca C; Macchi RM; Marschner AK; Mellstedt H
    Cancer Treat Rev; 2012 Feb; 38(1):68-75. PubMed ID: 21576002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of EpCAM and Wnt/ β-catenin in human colon cancer.
    Zhou FQ; Qi YM; Xu H; Wang QY; Gao XS; Guo HG
    Genet Mol Res; 2015 May; 14(2):4485-94. PubMed ID: 25966221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epithelial cell adhesion molecule: more than a carcinoma marker and adhesion molecule.
    Trzpis M; McLaughlin PM; de Leij LM; Harmsen MC
    Am J Pathol; 2007 Aug; 171(2):386-95. PubMed ID: 17600130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel therapeutic drug for colon cancer: EpCAM scFv-truncated protamine (tp)-siRNA.
    Hao H; Zhen Y; Wang Z; Chen F; Xie X
    Cell Biol Int; 2013 Aug; 37(8):860-4. PubMed ID: 23576466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EpCAM in carcinogenesis: the good, the bad or the ugly.
    van der Gun BT; Melchers LJ; Ruiters MH; de Leij LF; McLaughlin PM; Rots MG
    Carcinogenesis; 2010 Nov; 31(11):1913-21. PubMed ID: 20837599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [EpCAM a proteolytically cleaved oncogene and an excellent therapeutic target in cancer].
    Gires O
    Med Sci (Paris); 2009 May; 25(5):449-50. PubMed ID: 19480822
    [No Abstract]   [Full Text] [Related]  

  • 9. What is the relationship among microRNA-181, epithelial cell-adhesion molecule (EpCAM) and beta-catenin in hepatic cancer stem cells.
    Li JP; Zheng JY; Du JJ; Zhang R; Yang AG
    Hepatology; 2009 Dec; 50(6):2047-8; author reply 448. PubMed ID: 19937678
    [No Abstract]   [Full Text] [Related]  

  • 10. Glycosylation is crucial for stability of tumour and cancer stem cell antigen EpCAM.
    Munz M; Fellinger K; Hofmann T; Schmitt B; Gires O
    Front Biosci; 2008 May; 13():5195-201. PubMed ID: 18508581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional Implications of the Dynamic Regulation of EpCAM during Epithelial-to-Mesenchymal Transition.
    Brown TC; Sankpal NV; Gillanders WE
    Biomolecules; 2021 Jun; 11(7):. PubMed ID: 34209658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EpCAM: another surface-to-nucleus missile.
    Carpenter G; Red Brewer M
    Cancer Cell; 2009 Mar; 15(3):165-6. PubMed ID: 19249674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Initial activation of EpCAM cleavage via cell-to-cell contact.
    Denzel S; Maetzel D; Mack B; Eggert C; Bärr G; Gires O
    BMC Cancer; 2009 Nov; 9():402. PubMed ID: 19925656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EpCAM, a new marker for cancer stem cells in hepatocellular carcinoma.
    Terris B; Cavard C; Perret C
    J Hepatol; 2010 Feb; 52(2):280-1. PubMed ID: 20006402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nuclear signalling by tumour-associated antigen EpCAM.
    Maetzel D; Denzel S; Mack B; Canis M; Went P; Benk M; Kieu C; Papior P; Baeuerle PA; Munz M; Gires O
    Nat Cell Biol; 2009 Feb; 11(2):162-71. PubMed ID: 19136966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The tumour-associated antigen EpCAM upregulates the fatty acid binding protein E-FABP.
    Münz M; Zeidler R; Gires O
    Cancer Lett; 2005 Jul; 225(1):151-7. PubMed ID: 15922867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Members of the EpCAM signalling pathway are expressed in gastric cancer tissue and are correlated with patient prognosis.
    Warneke VS; Behrens HM; Haag J; Krüger S; Simon E; Mathiak M; Ebert MP; Röcken C
    Br J Cancer; 2013 Oct; 109(8):2217-27. PubMed ID: 24008668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EpCAM (CD326) finding its role in cancer.
    Baeuerle PA; Gires O
    Br J Cancer; 2007 Feb; 96(3):417-23. PubMed ID: 17211480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EpCAM and the biology of hepatic stem/progenitor cells.
    Dollé L; Theise ND; Schmelzer E; Boulter L; Gires O; van Grunsven LA
    Am J Physiol Gastrointest Liver Physiol; 2015 Feb; 308(4):G233-50. PubMed ID: 25477371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of the EpCAM (CD326) in prostate cancer metastasis and progression.
    Ni J; Cozzi PJ; Duan W; Shigdar S; Graham PH; John KH; Li Y
    Cancer Metastasis Rev; 2012 Dec; 31(3-4):779-91. PubMed ID: 22718399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.